Peer-influenced content. Sources you trust. No registration required. This is HCN.
Pharmacy Practice News
Pharmacists’ ability to provide off-label vaccines may be severely constrained… IDSA calls on insurers to continue covering COVID vaccines consistent with multiple medical society recommendations.
Family Medicine/General Practice October 14th 2025
Drugs.com
The more targeted vaccine formulation allows for administration of a smaller mRNA dose (10 mcg/0.2 mL) while achieving “higher seroresponse rates and geometric mean neutralizing antibody titer levels.”
Allergy & Immunology October 6th 2025
Medical Professionals Reference (MPR)
Capvaxive was noninferior to PPSV23 for each of the 12 serotypes present between the 2 vaccines and superior for each of the 9 serotypes unique to Capvaxive.
Cardiology September 16th 2025
Higher vaccine efficacy (13.5% [95% CI, -7.7, 30.6]) was observed with mNexspike vs the comparator in individuals aged 65 years and older.
Clinical Pharmacology September 3rd 2025
Infectious Disease Advisor
Future monitoring of VE is required to support ongoing policy decisions around the implementation of COVID-19 vaccines.
Family Medicine/General Practice August 27th 2025
Conexiant
Provision of antiviral therapy does not require a positive test for influenza when influenza is circulating in the community.
DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS